Intimation of the Voting Results and the Scrutinizers Report for the 78th Annual General Meeting of the Company held on Thursday, September 24, 2026.

Novartis India Limited September 25, 2026 The Secretary BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 Scrip Code - 500672 Dear Sir/Madam, Sub: Declaration of Voting Results of the 78th Annual General Meeting (‘AGM’) of Novartis India Limited (‘the Company’) held on Thursday, September 24, 2026, and Scrutinizers’ Report This has reference to our letter dated Thursday, September 24, 2026, and pursuant to Regulation 44 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the following: 1. Combined voting results of the remote e-Voting together with the voting conducted during the proceedings of the AGM, in relation to the items of business transacted at the AGM, attached and marked as Annexure - 1. 2. The Scrutinizer’s Report dated Friday, September 25, 2026, pursuant to Sections 108 of the Companies Act, 2013 read with Rules 20 of the Companies (Management and Administration) Rules, 2014 for the remote e-voting facility provided to the shareholders which commenced from 9.00 A.M. (IST) on Monday, September 21, 2026, and ended at 5.00 P.M. (IST) on Wednesday, September 23, 2026, and the e-voting conducted during the AGM held on Thursday, September 24, 2026, as Annexure – 2. The Voting Results along with the Scrutinizer's Report are also being made available on the websites of the Company at https://nilpharma.co.in/annual-general-meeting/ and National Securities Depository Limited at www.evoting.nsdl.com. You are requested to take the above information on record. Thank you. Yours Sincerely, For Novartis India Limited Chandni Maru Company Secretary and Compliance Officer A60291 Encl.: as above Registered Office: Inspire BKC, 7th Floor, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra, India. CIN: L24200MH1947PLC006104 | Tel: +91 22 50243000 Email: investor.relations@nilpharma.co.in | Website: www.nilpharma.co.in Novartis India Limited Annexure -I Format of Voting Results Date of declaration of Postal Ballot AGM/EGM September 24, 2026 Total number of shareholders on record date 38,952 (i.e. September 17, 2026) No. of shareholders present in the meeting either Not Applicable in person or through proxy: Promoters and Promoter Group: Public: No. of Shareholders attended the meeting through Video Conferencing: Promoters and Promoter Group: 3 Public: 50 Registered Office: Inspire BKC, 7th Floor, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra, India. CIN: L24200MH1947PLC006104 | Tel: +91 22 50243000 Email: investor.relations@nilpharma.co.in | Website: www.nilpharma.co.in Novartis India Limited Resolution Details (1) To receive, consider and adopt the Audited Balance Sheet as on March 31, 2026, and the Statement of Profit and Loss for the financial year ended March 31, 2026, together with the Reports of the Board of Resolution Required – Ordinary Directors and the Auditors thereon. Whether promoter/ promoter group are interested in the agenda/resolution? No % votes polled es - No. of No. of on No. of in Mode of shares votes outstanding votes - in Aga % of votes - in % of votes - in Category Voting held polled shares favour inst favour Against (3)= (6)=[(4)/(2)]*1 (7)=[(5)/(2)]*10 (1) (2) [(2)/(1)]*100 (4) (5) 00 0 E-voting 17450680 100 17450680 0 100 0 Poll 0 0 0 0 0 0 Postal Ballot(if Promoter applicabl e) 17450680 0 0 0 0 0 0 Promoter Group Total 17450680 17450680 100 17450680 0 100 0 E-voting 628365 91.97420363 628365 0 100 0 Poll 0 0 0 0 0 0 Postal Ballot(if applicable) 683197 0 0 0 0 0 0 Public Institutions Total 683197 628365 91.97420363 628365 0 100 0 E-voting 266726 4.067855029 266593 133 99.95013609 0.049863905 Poll 0 0 0 0 0 0 Postal Ballot applicable) 6556920 0 0 0 0 0 0 Public Non- Institutions Total 6556920 266726 4.067855029 266593 133 99.95013609 0.049863905 Total 24690797 18345771 74.3020608 18345638 133 99.99927504 0.000724963 Registered Office: Inspire BKC, 7th Floor, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra, India. CIN: L24200MH1947PLC006104 | Tel: +91 22 50243000 Email: investor.relations@nilpharma.co.in | Website: www.nilpharma.co.in Novartis India Limited Resolution Details (2) To regularize the appointment of Mr. Ashok Bhatia (DIN: 02090239), Additional Non-Executive Director, by appointing him as a Non-Executive Director of the Resolution Required – Ordinary Company. Whether promoter/ promoter group are interested in the agenda/resolution? No % votes polled es - No. of No. of on No. of in Mode of shares votes outstanding votes - in Aga % of votes - in % of votes - in Category Voting held polled shares favour inst favour Against (3)= (6)=[(4)/(2)]*1 (7)=[(5)/(2)]*10 (1) (2) [(2)/(1)]*100 (4) (5) 00 0 E-voting 17450680 100 17450680 0 100 0 Poll 0 0 0 0 0 0 Postal Ballot(if Promoter applicabl e) 17450680 0 0 0 0 0 0 Promoter Group Total 17450680 17450680 100 17450680 0 100 0 E-voting 628365 91.97420363 628365 0 100 0 Poll 0 0 0 0 0 0 Postal Ballot(if applicable) 683197 0 0 0 0 0 0 Public Institutions Total 683197 628365 91.97420363 628365 0 100 0 E-voting 266543 4.065064085 266364 179 99.93284386 0.067156144 Poll 0 0 0 0 0 0 Postal Ballot applicable) 6556920 0 0 0 0 0 0 Public Non- Institutions Total 6556920 266543 4.065064085 266364 179 99.93284386 0.067156144 Total 24690797 18345588 74.30131964 18345409 179 99.99902429 0.000975711 Registered Office: Inspire BKC, 7th Floor, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra, India. CIN: L24200MH1947PLC006104 | Tel: +91 22 50243000 Email: investor.relations@nilpharma.co.in | Website: www.nilpharma.co.in Novartis India Limited Resolution Details (3) To regularize the appointment of Mr. Kshitij Sheth (DIN: 00125058) Additional Non-Executive Director, by appointing him as a Non-Executive Director of the Resolution Required – Ordinary Company. Whether promoter/ promoter group are interested in the agenda/resolution? No % votes polled es - No. of No. of on No. of in Categor shares votes outstanding votes - in Aga % of votes - in % of votes - in y Mode of Voting held polled shares favour inst favour Against (3)= (7)=[(5)/(2)]*1 (1) (2) [(2)/(1)]*100 (4) (5) (6)=[(4)/(2)]*100 00 E-voting 17450680 100 17450680 0 100 0 Poll 0 0 0 0 0 0 Postal Promote Ballot(if r and applicable) 17450680 0 0 0 0 0 0 Promote r Group Total 17450680 17450680 100 17450680 0 100 0 E-voting 628365 91.97420363 628365 0 100 0 Poll 0 0 0 0 0 0 Postal Ballot(if Public applicable) 683197 0 0 0 0 0 0 Institutio ns Total 683197 628365 91.97420363 628365 0 100 0 E-voting 266543 4.065064085 266364 179 99.93284386 0.067156144 Poll 0 0 0 0 0 0 Public Postal Ballot (if Non- applicable) 6556920 0 0 0 0 0 0 Institutio ns Total 6556920 266543 4.065064085 266364 179 99.93284386 0.067156144 Total 24690797 18345588 74.30131964 18345409 179 99.99902429 0.000975711 Registered Office: Inspire BKC, 7th Floor, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra, India. CIN: L24200MH1947PLC006104 | Tel: +91 22 50243000 Email: investor.relations@nilpharma.co.in | Website: www.nilpharma.co.in Novartis India Limited Resolution Details (4) To regularize the appointment of Dr. Jagriti Gupta (DIN: 11760159) Additional Non-Executive Director, by appointing her as a Non-Executive Director of the Resolution Required – Ordinary Company. Whether promoter/ promoter group are interested in the agenda/resolution? No % votes polled es - No. of No. of on No. of in Mode of shares votes outstanding votes - in Aga % of votes - in % of votes - in Category Voting held polled shares favour inst favour Against (3)= (7)=[(5)/(2)]*1 (1) (2) [(2)/(1)]*100 (4) (5) (6)=[(4)/(2)]*100 00 E-voting 17450680 100 17450680 0 100 0 Poll 0 0 0 0 0 0 Postal Ballot(if Promoter applicabl e) 17450680 0 0 0 0 0 0 Promoter Group Total 17450680 17450680 100 17450680 0 100 0 E-voting 628365 91.97420363 628365 0 100 0 Poll 0 0 0 0 0 0 Postal Ballot(if applicable [Showing first 8,000 characters — download PDF for full document]